Investors must purchase Wipro shares by today, June 4th, to be eligible for the company's Rs 15,000 crore share buyback, as Friday, June 5t...

Wipro's Rs 15,000 crore share buyback, priced at a premium, is nearing its June 5 record date. Retail investors can potentially achieve dou...

Wipro has announced a Rs 15,000 crore share buyback. The record date is June 5, with shares to be repurchased at Rs 250 each. This offers a...

The 1987 film Wall Street introduced Gordon Gekko, a character who championed greed. Michael Douglas's iconic performance and the "Greed is...

SpaceX's IPO will grant Elon Musk unprecedented executive authority through supervoting shares, mandatory arbitration, and stricter shareho...

Sun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...

Wipro share buyback: IT services giant Wipro announced a significant Rs 15,000 crore share buyback at Rs 250 per share, a 19% premium over ...

Aurobindo Pharma has announced an ₹800-crore buyback at ₹1,475 per share, with April 17, 2026 set as the record date—meaning investors must...

Four companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo...

Musk may succeed, or not. But the ongoing uproar is certainly further proof that those who shout their liberalism from their rooftops or ar...

L&T, which has been pursuing a hostile takeover of Mindtree, has expressed its intent to ramp up its shareholding up to 66 per cent.

If the process drags on and generates substantial bad press, it can affect future growth of the company, says Everest Research CEO.

The brokerage firm added that the combined entity will have trailing 12-month (TTM) revenue of $837 million in BFSI.

The deal fulfils L&T’s long-cherished ambition for such an acquisition after its high profile, but unsuccessful attempt to acquire former s...

Kraft Foods' unsolicited bid for Cadbury has lifted M&A activity, but has also drawn attention to hostile takeovers.

Ranbaxy, which has been linked to a hostile takeover bid of Orchid Chemicals, has said it does not believe in such practices.

Most of the commentary on the prime minister’s call for moderation of promoter and senior executive salaries makes it clear that there are ...